Remarkably, IFNGR1KO tumors treated with ICT had complete remission in 5 out of 6 mice after 90 days (Fig. 7b, d) with no evidence of tumor formation by MRI, demonstrating that genetic knockout of IFNGR1 selectively sensitized RMC tumor cells to immunotherapy. This evidence concerns the gene IFNGR1 and neoplasm.